debate: to maintain or not to maintain in myeloma? - no, but if you must, use a proteasome inhibitor
Published 10 years ago • 59 plays • Length 15:31Download video MP4
Download video MP3
Similar videos
-
17:26
debate: to maintain or not to maintain? immunomodulators vs. pi - yes (proteasome inhibitors)
-
9:02
debate: to maintain or not to maintain in myeloma? - yes, use imids
-
15:59
debate: to maintain or not to maintain? immunomodulators vs. pi - no
-
11:25
debate: to maintain or not to maintain? immunomodulators vs. pi - yes (imids)
-
2:35
myeloma uk proteasome inhibitors in myeloma
-
13:19
using the immune system to fight multiple myeloma
-
10:11
what is multiple myeloma? | hematologic system diseases | nclex-rn | khan academy
-
2:01
video 20 waldenstrom's macroglobulinemia
-
14:01
imid plus monoclonal antibody?
-
10:24
debate: high risk myeloma: should it be treated differently? - yes
-
13:17
debate: induction therapy for multiple myeloma - based on an imid and a proteasome inhibitor
-
11:58
debate: do molecular characteristics play a role in selecting patients for metastasectomy? - no
-
20:51
car-t: state of the art and perspective of a possible cure
-
21:09
minimal residual disease (mrd) in cll: is it clinically relevant?
-
2:26
should patients see a multiple myeloma expert?
-
9:38
debate: which initial therapy for younger fit patients is best? - krd and vrd
-
12:00
debate: is allotransplant relevant today in myeloma? - no
-
17:36
one size fits all for induction therapy in myeloma: what you need to know
-
21:42
2013 annual hematology meeting: multiple myeloma - upfront therapy
-
30:24
case presentations: waldenström macroglobulinemia
-
18:56
what is the best induction for transplant-eligible myeloma patients?